CAS 81919-14-4
:L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
Description:
L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1), identified by CAS number 81919-14-4, is a chemical compound that combines the amino acid lysine with an indazole derivative. This compound features a lysine backbone, which is essential for protein synthesis and plays a crucial role in various metabolic processes. The presence of the indazole moiety contributes to its potential biological activity, possibly influencing its interaction with biological targets. The acetate group suggests that the compound may exhibit solubility in polar solvents, which can affect its bioavailability and pharmacokinetics. As a result, this compound may be of interest in pharmaceutical research, particularly in the development of therapeutic agents. Its structural characteristics may also imply specific reactivity patterns and stability under various conditions. However, detailed studies would be necessary to fully elucidate its properties, including its mechanism of action, efficacy, and safety profile in biological systems.
Formula:C16H14N2O3·C6H14N2O2
InChI:InChI=1S/C16H14N2O3.C6H14N2O2/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12;7-4-2-1-3-5(8)6(9)10/h1-9H,10-11H2,(H,19,20);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1
InChI key:InChIKey=OCOCFNMFLNFNIA-ZSCHJXSPSA-N
SMILES:C(N1C=2C(C(OCC(O)=O)=N1)=CC=CC2)C3=CC=CC=C3.[C@H](CCCCN)(C(O)=O)N
Synonyms:- 2,6-diammoniohexanoate [(1-benzyl-1H-indazol-3-yl)oxy]acetate
- <span class="text-smallcaps">L</span>-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
- <span class="text-smallcaps">L</span>-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]
- Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. with <span class="text-smallcaps">L</span>-lysine (1:1)
- Af 1934
- Bendaline
- Bendazac <span class="text-smallcaps">L</span>-lysine salt
- Bendazac lysine
- Bendazac lysine salt
- Bendazaclysine
- L-Lysine-(1-benzyl-1H-indazol-3-yloxy)acetic acid
- Bendazac L-lysine salt
- Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. with L-lysine (1:1)
- L-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
(2S)-2,6-diaminohexanoic acid; 2-[(1-benzyl-1H-indazol-3-yl)oxy]acetic acid
CAS:Formula:C22H28N4O5Purity:98%Color and Shape:SolidMolecular weight:428.4815(S)-2,6-Diaminohexanoic Acid 2-((1-Benzyl-1H-Indazol-3-Yl)Oxy)Acetic Acid Salt
CAS:<p>(S)-2,6-Diaminohexanoic Acid 2-((1-Benzyl-1H-Indazol-3-Yl)Oxy)Acetic Acid Salt</p>Purity:98%Molecular weight:428.48g/molBendazac L-lysine
CAS:<p>Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients.</p>Formula:C22H28N4O5Purity:99.85%Color and Shape:WhiteMolecular weight:428.48Bendazac L-Lysine
CAS:Controlled ProductFormula:C16H14N2O3·C6H14N2O2Color and Shape:NeatMolecular weight:428.481Bendazac L-lysine
CAS:Controlled Product<p>Bendazac L-lysine is a coumarin derivative that is used in pharmaceutical preparations for the treatment of diabetic neuropathy. It has been shown to increase the levels of growth factors, such as insulin-like growth factor-1 and vascular endothelial growth factor, in diabetic patients. Bendazac L-lysine can be prepared by high performance liquid chromatography (HPLC) using preparative reverse phase HPLC. The fluorescence spectrometry of bendazac L-lysine was measured at 230 nm with excitation at 220 nm and emission at 255 nm. Bendazac L-lysine has also been shown to have an absorption enhancer effect on lysine, a necessary amino acid for collagen synthesis.</p>Formula:C22H28N4O5Purity:Min. 95%Molecular weight:428.48 g/mol







